VeriSIM partners with Clarivate for early-stage drug development
The two companies will combine tools to ‘accelerate’ and ‘de-risk’ the drug development process.
Stay updated with breaking news from Linical Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The two companies will combine tools to ‘accelerate’ and ‘de-risk’ the drug development process.
Since 1978, the US Food and Drink Administration has had in place the guidance for good laboratory practices (GLP) regulations.
Galapagos NV has announced it has initiated a phase 3 study with small molecule drug filgotinib in patients with the chronic, highly inflammatory condition, active axial spondyloarthritis(AxSpA).
Chiesi partners with BioLabs to gain access to certain sites and work with the companies using the facilities to advance rare disease research.
Since 1978, the US Food and Drink Administration has had in place the guidance for good laboratory practices (GLP) regulations.